ClinicalTrials.gg
Status unknownNCT04373993Updated May 13, 2024

Prehospital Minutes Count During a Stroke.

An observational study in Stroke, Acute, sponsored by Nordlandssykehuset HF. Status unknown at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-13.

Sponsored by Nordlandssykehuset HF · Observational

The sponsor has not verified this record recently (last verified Mar 2024), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,100
Ages
18 Years and older
Sex
All
01

Study summary

The ultimate objective is to improve the efficacy of prehospital procedures for patients suffering an acute stroke. Increased precision in prehospital selection and a more efficient transport chain will lead to an even more rapid start of treatment and thus benefit patients. The research project has two parts: one part collecting data from medical reports and one study with qualitative in-depth interviews. The project will gather data from various parts of Norway and from a University hospital in Switzerland for comparison between regions and countries. Data will be retrieved through intrahospital and prehospital medical records from various parts of Norway (Nordland Hospital, Akershus University Hospital and Helgeland Hospital) and from Basel University hospital in Switzerland. Knowledge of factors associated with delays will be compared for regions in the north and south of Norway, as well as abroad. The information obtained will be analysed to identify components in the chain that may be improved as concerns time saving.

02

Conditions studied

  • Stroke, Acute

Browse trials for

03

In context

Stroke

7,443 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's planned enrollment of 1,100 is above the median of 160 across 1,729 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Nordlandssykehuset HF is the lead sponsor of 21 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients discharged from the respective hospitals with a diagnosis of stroke during the period of inclusion.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Final diagnosis of stroke at discharge from hospital

Exclusion criteria

Exclusion Criteria:

  • Hospital admission later than one week from stroke onset
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Nordlandssykehuset HF
  • Akershus universitetsssykehus
  • Helgelandssykehuset
  • Basel University Hospital
06

What researchers measure

Primary outcomes

  1. Time delay from ictus to hospital arrival

    Delay from first symptoms of stroke until arrival at hospital

    Time frame: Within 4 hours

07

Study locations

1 site
  • Maria Carlsson
    Bodø, 8092, Norway
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2018 to primary completion in Dec 2023, 66 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2020
First posted
May 5, 2020
StartActual
Jun 1, 2018
Primary completionActual
Dec 1, 2023
CompletionEst.
Jun 30, 2025
Last update
May 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04373993
Lead sponsor
Nordlandssykehuset HF
Responsible party
Sponsor
First posted
May 5, 2020
Start date
Jun 1, 2018
Primary completion
Dec 1, 2023
Completion
Jun 30, 2025 (estimated)
Last update
May 13, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion